Ever since I started investing in stock, I have made several good choices with pharmaceutical firms; MedImmune, Genentech, and now Dendreon.
MedImmune and Genentech both were acquired when I was a shareholder.
Dendreon has been rising with speculation of FDA approval on/before May 1st.
Now for a brief summary of investment history:
The company that I watched and missed opportunity is: Oakley, Human Genome Science, Bank of America
The company that I lost money on: Wendy's, Jamba Juice
The company that I watched but sold too early: Jamba Juice, Northwest Airline, Visa
The company that I AM WATCHING today: Motorola, Google, Baidu, LDK Solar, Canadian Solar, Human Genome Science, Citigroup, Dendreon, AspenBio Pharma, BioMarin Pharma, Gilead Science, Apple, Amazon, Disney, eBay, Allos Therapeutics, CSX Corporation (these are major ones, I follow multiple number of these).
*I'm not listing investment I made $ on, as it is too long to write, but you can look back at my old articles and see.
[Articles worth your time to Read]
Allos Therapeutics: http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3184
AspenBio: http://seekingalpha.com/article/200128-will-aspenbio-pharma-follow-in-dendreon-and-human-genome-sciences-footsteps
Dendreon: "If you use that assumption and say that the market size is 100,000, men then the total commercial market opportunity for Provenge is $8 billion, " by Adam F. http://www.thestreet.com/print/story/10503521.html
Blog on DNDN by Jim Edwards: http://industry.bnet.com/pharma/10007824/dendreon-preview-drama-could-culminate-in-the-first-cancer-vaccine-approval/?tag=shell;content
Dendreon Presentation: http://www.prnewswire.com/news-releases/dendreon-presents-data-at-american-association-for-cancer-research-supporting-mechanism-of-action-of-provenge-91691929.html
CSX Corporation, which I believe Warren put huge investment like about a year ago: http://www.schaeffersresearch.com/commentary/content/early+edge+csx+corp+goldman+sachs+group+dendreon+corp+and+sunpower/observations.aspx?ID=99211
